Dr Ramil Mansourov, MD | |
235 Main St, Norwalk, CT 06851-2720 | |
(203) 644-4775 | |
(203) 547-6118 |
Full Name | Dr Ramil Mansourov |
---|---|
Gender | Male |
Speciality | Multi-specialty |
Location | 235 Main St, Norwalk, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1992768477 | NPI | - | NPPES |
26162 | Other | ND | BCBS |
12543 | Medicaid | ND |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 9376 (North Dakota) | Secondary |
207P00000X | Emergency Medicine | 44050 (Kentucky) | Secondary |
193200000X | Multi-specialty | 040028 (Connecticut) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Ramil Mansourov, MD 235 Main St, Norwalk, CT 06851-2720 Ph: (203) 644-4775 | Dr Ramil Mansourov, MD 235 Main St, Norwalk, CT 06851-2720 Ph: (203) 644-4775 |
News Archive
The House is expected to pass an abortion-related bill today, but like other similar legislation, it is not likely to make progress in the Democrat-controlled Senate. Meanwhile, a number of other health-related measures and subjects are moving on both sides of the Capitol, including a rural health proposal and another related to a health tax credit aimed at easing the contractor tax compliance burden. Lastly, two Senate Democrats expressed concerns about the Prevention Trust Fund's advisory panel.
A new study from the University of Copenhagen's OPUS Research Centre reports that being overweight makes children less active. The findings underscore that parents of overweight children have an obligation to keep their children active, as physical activity is vital for the general health of all children. The study also shows that slender children do not become overweight due to a lack of activity.
Anergis SA announced today that it has closed a Series A financing round raising CHF 18 millions from European biotech funds and private local investors.
Whenever humans create a new antibiotic, deadly bacteria can counter it by turning into new, indestructible super-bugs.
SRI International, an independent nonprofit research and development organization, announced today the award of U.S. patent 7,592,021 for a new bioadhesive drug delivery system that enables enhanced release of drugs through the human body's mucous membranes.
› Verified 2 days ago